In key en­dorse­ment, Deer­field re­serves $65M for drug ven­ture with UNC-Chapel Hill

Last Oc­to­ber, Deer­field Man­age­ment teamed up with the Broad In­sti­tute of MIT and Har­vard for a nov­el ap­proach to pur­su­ing trans­la­tion­al re­search. Just over a year lat­er, the mar­quee health­care in­vest­ment firm is look­ing be­yond the heart of the Boston/Cam­bridge biotech hub for its next deal.

With $65 mil­lion in tar­get­ed fund­ing, Deer­field is com­mit­ting to bankroll and sup­port drug re­search com­ing out of the Uni­ver­si­ty of North Car­oli­na, Chapel Hill, through a new com­pa­ny.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER